Rahman Ziyaur, Kohli Kanchan, Khar Roop K, Ali Mushir, Charoo Naseem A, Shamsher Areeg A A
Department of Pharmaceutics, F/O Pharmacy, Hamdard University, New Delhi-110063 India.
AAPS PharmSciTech. 2006 May 26;7(2):E47. doi: 10.1208/pt070247.
The purpose of this investigation was to prepare and evaluate the colon-specific microspheres of 5-fluorouracil for the treatment of colon cancer. Core microspheres of alginate were prepared by the modified emulsification method in liquid paraffin and by cross-linking with calcium chloride. The core microspheres were coated with Eudragit S-100 by the solvent evaporation technique to prevent drug release in the stomach and small intestine. The microspheres were characterized by shape, size, surface morphology, size distribution, incorporation efficiency, and in vitro drug release studies. The outer surfaces of the core and coated microspheres, which were spherical in shape, were rough and smooth, respectively. The size of the core microspheres ranged from 22 to 55 microm, and the size of the coated microspheres ranged from 103 to 185 microm. The core microspheres sustained the drug release for 10 hours. The release studies of coated microspheres were performed in a pH progression medium mimicking the conditions of the gastrointestinal tract. Release was sustained for up to 20 hours in formulations with core microspheres to a Eudragit S-100 coat ratio of 1:7, and there were no changes in the size, shape, drug content, differential scanning calorimetry thermogram, and in vitro drug release after storage at 40 degrees C/75% relative humidity for 6 months.
本研究的目的是制备并评估用于治疗结肠癌的5-氟尿嘧啶结肠靶向微球。通过改良乳化法在液体石蜡中制备藻酸盐核微球,并与氯化钙交联。采用溶剂蒸发技术用Eudragit S-100包衣核微球,以防止药物在胃和小肠中释放。通过形状、大小、表面形态、粒径分布、包封率和体外药物释放研究对微球进行表征。核微球和包衣微球的外表面分别为粗糙和光滑的球形。核微球的大小范围为22至55微米,包衣微球的大小范围为103至185微米。核微球可持续释放药物10小时。在模拟胃肠道条件的pH梯度介质中进行包衣微球的释放研究。在核微球与Eudragit S-100包衣比例为1:7的制剂中,释放可持续长达20小时,在40℃/75%相对湿度下储存6个月后,微球的大小、形状、药物含量、差示扫描量热图谱和体外药物释放均无变化。